V3V.F VITA 34 AG

Healthcare Health Care Providers & Services Frankfurt Exchange
2.31 EUR
Close of Nov 12, 2026
2.31 6.75
Market cap
EUR 41.0M
P/E
-
P/B
8.26x
ROE
-52.3%
Dividend yield
0.00%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is V3V.F undervalued?

Graham number

The Graham number of VITA 34 AG cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

VITA 34 AG fundamental analysis

No fundamental analysis for VITA 34 AG yet.

VITA 34 AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About VITA 34 AG

FamiCord AG engages in the collection, processing, storage, and distribution of cells, tissues, blood, and blood components for medical applications in Germany, Poland, Switzerland, Portugal, and internationally. The company operates through Subgroup Vita 34 And Subgroup PBKM segments. It produces and develops advanced therapies, genetic tests, and analyses for third parties. The company also engages in the development and manufacture of cell and tissue-based products and ph…

Full company profile